An international team has reported findings from an independent assessment of five commercially available ctDNA assays as a method to […]
Liquid biopsy has the promise to revolutionise cancer care and treatment, allowing the detection of rare cell types with a […]
Researchers find that cell-free circulating tumour DNA (ctDNA) analyses before and during treatment could help guide selection of therapy for […]
A recent review, published in Cancers, has summarised the current landscape of ctDNA analysis in clinical practice as well as […]
Researchers have validated the use of circulating tumour DNA (ctDNA) and metabolites in cerebrospinal fluid (CSF) as potential biomarkers for […]
Written by Poppy Jayne Morgan A new study in ESMO Open has identified a faster and more accurate diagnosing tool […]
Written by Charlotte Harrison, Science Writer Liquid biopsy assays that detect circulating tumour (ct) DNA are safer and faster than […]
One of the most exciting applications of cancer genomics is the development of liquid biopsies. By measuring circulating tumour cells […]
Researchers have conducted a comprehensive genetic analysis to estimate the polygenic genetic overlap between 316 unique blood metabolite levels and […]
Researchers have explored whether a sequencing approach, called HPV-seq, could improve detection of the human papillomavirus in patients with low […]
